NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









RiboPro

RiboPro

Private
OssHealthcare & Life Scienceshttps://ribopro.eu/

Last Round

Series A

Oct 31, 2024

Total Funding Raised

$7.56M

Company Overview

RiboPro is a biotechnology company that provides messenger RNA (mRNA) and lipid nanoparticle (LNP) development and manufacturing services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationmessenger RNAmRNACDMOLNPlipid nanoparticlemRNA manufacturingGMP manufacturingLNP formulationmRNA synthesisCROmRNA therapeuticsmRNA vaccinescontract research organizationsequence designsaRNAcircRNAtechnology licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RiboPro Comparables

Compare RiboPro with similar companies based on industry and business-model similarity.

RiboPro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

RiboPro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 31, 2024
Convertible DebtJan 10, 2024
GrantOct 27, 2021
SeedMar 22, 2021

Key People

Founding team and executive leadership

Sigi Neerken

Chief Operating Officer

Executive Team

Silvy Van Tuijl

COS, COO

Executive Team

RiboPro Investors

Notable investors and investment history

RiboPro investors
InvestorRounds
Mountainview Capital PartnersSeries A
RockstartSeed, Series A
Brabantse Ontwikkelings MaatschappijConvertible Debt, Seed
CEPIGrant
Wellcome LeapGrant
BOM Brabant VenturesSeries A
Vlasroot GroupConvertible Debt, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors increased 129% MoM, reaching 1.3K.

  • Jul 6, 2025

    Monthly visitors grew 67% MoM, reaching 2,000.

RiboPro Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RiboPro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RiboPro's valuation, stock price, and market status.

Firmographic Details

HeadquartersOss
Employee Range40
Year Founded2020
Last FundingOct 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.